The combination of B7.1, ICAM-1 and LFA-3 (TRICOM) appears to be particularly useful for both in vitro stimulation of T cells and for induction of tumor rejection in vivo [18,19,24,26]. The gene discussed is CD58; the disease is neoplasm.